GlaxoSmithKline

Management Perspective

BY: Muhammad Bilal Khawaja - 13893 Muhammad Noman Khan - 13836 S.M. Zeeshan 13910

Agenda
Pakistan Pharmaceutical Industry GSK at a glance History Market Share Objectives Problems and issues SWOT Analysis Action programs Action plans Financial projections Milestones Controls

Pakistan Pharma Industry

Major Pharma Companies
Johnson & Johnson Pfizer GSK Roche Novartis Sanofi-Aventis Abbott Laboratories

GSK at a glance
As no. 1 pharmaceutical company in Pakistan With mission Do more | Feel better | Live longer Deals in
PHARMACEUTICAL BIOLOGICS VACCINES CONSUMER HEALTHCARE COMPANY

GSK at a glance
Vision
The Opportunity to make a difference to the lives of the billions of people

Values
Transparency Integrity Respect for People Patient Focus

GSK Products

History
1947 1949 Glaxo operations organized in Pakistan at Independence SK&F came to Pakistan under the name of Pharmaco limited Glaxo became public limited. Beecham incorporated in Pakistan Glaxo established manufacturing facilities in Pakistan. Wellcome incorporated in Pakistan

1952 1954 1955

1955

History
1956 1979 1996 2002 Wellcome established manufacturing facilities in Pakistan Wellcome Pakistan Became Public Limited Glaxo and Wellcome merged to become Glaxo Wellcome Glaxo Wellcome, Beecham And Sk&f Integrated As a result Of Global Merger To Form GlaxoSmithKline Stiefel (dermatological pharmaceutical) was acquired by GlaxoSmithKline

2009

Achievements
2005 Excellence Award in Best Practices by Occupational, Health and safety by Employers Federation of Pakistan 2006: 50 Star Rating from the Global internal Audit, Highest in the Industry 2007: Most Prefered Pharmaceutical Company, by Pakistan Society for Human Resource Manager

Achievements
Also Received for Best Management Practices by the management association of Pakistan 2009: Annual Environment Excellence Award in recognition of its policies on safe guarding health

Market Share
Names GSK Sanofi-Aventis Getz Pharma Abbott Lab Roche Merck Market Share 13.80% 4.10% 3.90% 3.80% 3.10% 2.90%

Market Share

Objectives
Expansion Consistent Price across the board Research Based Product Launches Growth with Sustainability

Organizational Chart

Problems and Issues

Increased Competition Changing consumer profile Rupee Depreciation Decreasing Consumer Influence Policies and Guidelines Implementations Security Issue

SWOT Analysis
STRENGTHS
Strong infrastructure Industry-leading early to mid-stage R&D pipeline Life-cycle management strategies Strong business fundamentals and robust balance sheet Demonstrated ability to drive cost elimination

SWOT Analysis
WEAKNESSES
Mature portfolio of marketed products High dependence on low growth/highly competitive Failure of R&D pipeline

SWOT Analysis
OPPORTUNITIES Potential for inspired R&D pipeline Enhanced vaccine offering Movement into high growth oncology market Movement into biologics Continued cost elimination Strong cash position facilitates

SWOT Analysis
THREATS Launch of new generics by competitors Counterfeiting Unethical practices by competitors Pricing control Changing Consumer Profile Decreasing consumer influence Policies and Guidelines Implementations

Competitive Forces

External Environment
Competitive Forces
Potential Development of Substitute Product Bargaining Power of Supplier Bargaining Power Of Consumers

Economic Forces Social and Demographic Forces Technological Forces Political Forces

Action Programs
Developing strategies
Grow a diversified global business Deliver more products of value Simplify the operating model Create a culture of individual empowerment Building trust

Action Plans
Implementation of generics in Pakistan Launching new products Futuristic plan Focus on Research Aggressive Marketing And Promotion Traditional marketing Digital marketing

Financial Projections

Milestones
Augmentin became the first ever 3 billion products in Pakistan during 2011. GSK is ranked no.1 in terms of value GSK is ranked no.1 in terms of volume GSK is ranked no.1 in terms of prescription GSK has 8 products in the top 20 products in terms of value.

Milestones
GSK has 10 products in the top 20 products in terms of volume GSK has 6 products in the top 20 products in terms of prescription Approx. 600,000 prescriptions are written every day for GSK products in Pakistan Approx. 10 million GSK tablets are consumed each day in Pakistan Approx. 4.3 million teaspoons of GSK products are consumed each day

Controls
Feedback Mechanism
360 Degree Review Process

Control Mechanism
Internal Control
Audit Committee
Corporate Governance Financial Reporting

Questions